In preclinical models of pancreatic cancer, it was observed that an increased ratio of myCAF to iCAF induced by leukemia inhibitory factor (LIF) inhibited cancer cell proliferation through deposition of ECM proteins that in turn resulted in regression of tumor growth. Here, LIF is linked to pancreatic neoplasm.